A Rapamycin-Based GMP-Compatible Process for the Isolation and Expansion of Regulatory T Cells for Clinical Trials. (Q52725822)
Jump to navigation
Jump to search
scientific article published on 31 January 2018
Language | Label | Description | Also known as |
---|---|---|---|
English | A Rapamycin-Based GMP-Compatible Process for the Isolation and Expansion of Regulatory T Cells for Clinical Trials. |
scientific article published on 31 January 2018 |
Statements
A Rapamycin-Based GMP-Compatible Process for the Isolation and Expansion of Regulatory T Cells for Clinical Trials. (English)
Henrieta Fraser
Niloufar Safinia
Nathali Grageda
Sarah Thirkell
Katie Lowe
Laura J Fry
Andrew Hope
Christopher Fisher
Rachel Hilton
David Game
Paul Harden
Andrew Bushell
Kathryn Wood
Robert I Lechler
Giovanna Lombardi
31 January 2018
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference